Continuus Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
25R Olympia Ave, Woburn, Massachusetts, ...Phone Number
(781) 281-0099Website
www.continuuspharma.comRevenue
$16.9 MillionIndustry
About Continuus Pharmaceuticals
CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. The company specializes in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance. With ICM, the company will improve affordability and accessibility of pharmaceuticals on a global scale.Explore more
Continuus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Continuus Pharmaceuticals
Compare insights from companies similar to Continuus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Continuus Pharmaceuticals Tech Stack
A closer look at the technologies used by Continuus Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Continuus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. The company specializes in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance.... Read More
